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Although the nuclear vitamin D receptor (VDR) is
involved in the control of keratinocyte proliferation and
differentiation by its ligand 1,25-dihydroxyvitamin D3
[1,25(OH)2D3], its role in epidermal physiology remains
poorly understood. Because VDR abundance reflects
cellular responsiveness to 1,25(OH)2D3, we investigated
VDR expression in cultured human keratinocytes and
identified cell anchorage and cytoskeletal integrity as
essential requirements for the maintenance of VDR levels.
Suspension culture rapidly suppressed VDR expression
and 1,25(OH)2D3 responsiveness (as estimated by induc-
tion of 24-hydroxylase mRNA), due to decreased tran-
scription of the VDR gene. Concomitantly, overt growth
arrest with p21WAF1 induction and cyclin D1 and c-
myc suppression occurred, together with induction of
As they leave the epidermal basal layer, keratinocyteswithdraw from the cell cycle and undergo a carefullyorchestrated programme of terminal differentiation. Dur-ing this process, keratinocytes exhibit a wide array ofbiochemical and morphologic changes characterized by
the loss of integrin expression and adhesiveness to the extracellular
matrix, a switch to suprabasal keratin expression, the accumulation of
proteins (involucrin, small proline rich proteins, loricrin, etc.), which
are cross-linked by the enzyme transglutaminase I to form a cornified
envelope, and changes in lipid synthesis. Through this sequence of
events, keratinocytes are transformed into corneocytes establishing the
barrier function of the skin (Eckert et al, 1997a). An attractive model
to study epidermal keratinocyte differentiation in vitro is suspension
culture in semisolid medium, where keratinocytes undergo growth
arrest, differentiation, and finally apoptosis (Rheinwald and Beckett,
1980; Adams and Watt, 1989; Frisch and Ruoslahti, 1997).
The vitamin D receptor (VDR), a member of the nuclear receptor
superfamily (Mangelsdorf et al, 1995), is activated by its ligand 1,25-
dihydroxyvitamin D3 [1,25(OH)2D3] to regulate the transcription of
target genes, usually after heterodimerization with retinoid X receptor
(RXR) (Haussler et al, 1997). Apart from its function in bone
formation and calcium metabolism, new actions have been ascribed to
1,25(OH)2D3 in the control of proliferation and differentiation of a
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differentiation markers and retinoid X receptor a, the
heterodimeric partner for VDR. Reattachment of sus-
pended keratinocytes to fibronectin led to a rapid restora-
tion of VDR expression, which could be blocked by
RGD peptides or a blocking anti-b1 integrin antibody.
VDR expression was also reduced by disruption of the
actin cytoskeleton with cytochalasin D. Malignant ker-
atinocytes (SCC12B2 and A431), characterized by
anchorage-independent growth, displayed a profound
resistance to suspension-induced suppression of VDR,
cyclin D1, and c-myc. Taken together, our results associ-
ate VDR expression [and 1,25(OH)2D3 responsiveness]
with cell adhesion and an organized cytoskeleton, which
are also required for cell growth of primary cells. Keywords:
cell adhesion/epidermal cells/receptors, calcitriol/retinoid X
receptor. J Invest Dermatol 111:551–558, 1998
variety of cells and tissues (Bouillon et al, 1995). Epidermal keratinocytes
occupy a pivotal position in the vitamin D endocrine system by the
photochemical synthesis of vitamin D3, the 1α-hydroxylation of 25-
OH-vitamin D3 and the presence of VDR (Bikle and Pillai, 1993).
Moreover they respond to 1,25(OH)2D3 treatment with growth arrest
and differentiation (Bikle and Pillai, 1993). This knowledge has been
successfully applied in the use of vitamin D analogs for the therapy of
the hyperproliferative skin disease psoriasis (van de Kerkhof, 1995;
Fogh and Kragballe, 1997). In spite of these obvious pharmacologic
effects of 1,25(OH)2D3, the exact function of the vitamin D receptor
and its ligand in epidermal physiology remain poorly understood. VDR
emerges in the skin early in embryonic life (Johnson et al, 1996),
however, and its cutaneous expression seems to be developmentally
regulated with increasing levels in the late fetal and neonatal period
(Horiuchi et al, 1985). Moreover VDR knockout mice (Li et al, 1997a;
Yoshizawa et al, 1997) and patients with hereditary 1,25(OH)2D3
resistance (Malloy et al, 1997) exhibit a striking phenotype with total
alopecia, further supporting the involvement of VDR in epidermal
homeostasis.
Because tissue responsiveness to steroid hormones [including
1,25(OH)2D3] depends on the abundance of the receptor (Hewison
et al, 1994; Chen et al, 1996; Krishnan and Feldman, 1997), expression
patterns of a nuclear receptor may provide important clues for its
function. Apart from homologous regulation by 1,25(OH)2D3 (Solvsten
et al, 1997), not so much is known about the regulation of VDR
expression in cultured keratinocytes. In searching for other factors that
determine VDR expression in keratinocytes, we investigated the role
of adhesion to the extracellular matrix and cytoskeletal integrity. Indeed,
cell–matrix interactions were shown to be crucial in the control of
epidermal proliferation and differentiation (Watt and Hertle, 1994),
processes for which a role has also been proposed for 1,25(OH)2D3
(and VDR). We report that disruption of both cell–matrix interactions
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by suspension culture or the actin cytoskeleton by cytochalasin D,
results in a rapid and marked suppression of VDR expression and
1,25(OH)2D3 responsiveness in cultured human keratinocytes. Because
cell-substratum adhesion and cytoskeletal integrity are coordinately
required not only for the growth of untransformed cells (Assoian,
1997), but also for VDR expression, our results are in support of a
link between cell proliferation and VDR expression (Manolagas et al,
1987; Krishnan and Feldman, 1991).
MATERIALS AND METHODS
Cell culture and reagents Human foreskin keratinocytes of young donors
(less than 6 y old) were isolated and cultured as described (Segaert et al, 1997)
in keratinocyte serum-free medium (GIBCO BRL, Gaithersburg, MD) with a
calcium concentration of 0.09 mM and supplemented with 50 µg bovine
pituitary extract (GIBCO BRL) per ml and 5 ng human epidermal growth
factor (GIBCO BRL) per ml. Suspension culture was carried out as described
(Watt, 1994). Briefly, after trypsinization, keratinocytes were suspended in
keratinocyte serum-free medium (107 per ml). This liquid suspension was then
diluted (1:10) in keratinocyte serum-free semisolid medium containing the
aforementioned supplements and 2% methylcellulose (Aldrich, Bornem,
Belgium) and incubated on 0.4% poly(2-hydroxyethylmethylacrylate) (Sigma,
St. Louis, MO) coated dishes. Harvesting of the cells was achieved by diluting
the medium with phosphate-buffered saline (PBS) and centrifugation of the
cells. A431 cells [human vulvar squamous cell carcinoma, American Type
Culture Collection (ATCC), Rockville, MD] and SCC12B2 (human facial
squamous cell carcinoma) (Rheinwald and Beckett, 1980) were maintained in
culture like the normal keratinocytes. For some experiments, dishes were coated
with fibronectin (Boehringer, Indianapolis, IN) (1 µg per ml in PBS) overnight
at 4°C. After rinsing with PBS, the dishes were blocked with heat denatured
bovine serum albumin (0.5 mg per ml in PBS) for 1 h at 37°C, followed by
PBS rinsing. To inhibit attachment of cells to fibronectin we used anti-human
integrin β1 (mouse monoclonal, clone P4C10; GIBCO BRL) or the RGD
peptide Gly-Arg-Gly-Asp-Thr-Pro (Sigma). Actinomycin D and cytochalasin
D were purchased from Sigma and dissolved in dimethylsulfoxide. 1,25(OH)2D3
(gift from Dr. Uskokovic, Hoffman-La Roche, Nutley, NJ) was used from a
stock in absolute ethanol.
Northern blot analysis Total cellular RNA was prepared by lysing the cells
in cold guanidine isothiocyanate buffer, followed by ultracentrifugation on a
cesiumchloride gradient. RNA (12 µg) was fractionated by formaldehyde 1%
agarose gel electrophoresis, blotted to a nylon membrane (Hybond N,
Amersham, Arlington Heights, IL) and fixed by UV cross-linking. Prehybridiza-
tion and hybridization were performed in 50% formamide, 5 3 Denhardt’s,
6 3 sodium citrate/chloride buffer, 0.1% sodium dodecyl sulfate, 50 mM
sodium phosphate pH 7.0, denatured herring sperm DNA (200 µg per ml) at
42°C. DNA probes were labeled with α32P-dCTP (Amersham) by random
priming (Oligolabelling kit, Pharmacia Biotech, Piscataway, NJ). Blots were
washed under increasingly stringent conditions (last step in 0.1 3 sodium
citrate/chloride buffer; 0.1% sodium dodecyl sulfate) and autoradiographed.
The following DNA probes were used: human VDR cDNA (ATCC; Baker
et al, 1988), human retinoid X receptor α (RXRα) cDNA (Elder et al, 1992),
human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA (Chen et al, 1993),
human WAF1 cDNA (El-Deiry et al, 1993), a 0.479 kb human c-myc probe
prepared with a reverse transcriptase-polymerase chain reaction amplimer set
(Clontech, Palo Alto, CA), human cyclin D1 cDNA (Xiong et al, 1991), a
human transglutaminase I probe (ATCC; Phillips et al, 1990), and a small
proline rich protein 1 (SPR 1) probe (Gibbs et al, 1993). For verification of
even loading we used a probe for glyceraldehyde-3-phosphate dehydrogenase
or 18S RNA (in the case of long-term suspension culture affecting glyceral-
dehyde-3-phosphate dehydrogenase expression).
Immunoblot analysis Keratinocytes were scraped in lysis buffer (150 mM
NaCl, 50 mM Tris-Cl pH 8.0, 5 mM ethylenediamine tetraacetic acid, 1%
Nonidet p-40) containing 1 mM phenylmethylsulfonyl fluoride, 10 µg leupeptin
per ml, 10 µg aprotinin per ml, and 1 µg antipain per ml. Protein concentration
was determined using the BCA Protein Assay Reagent (Pierce, Rockford, IL).
The extracts were mixed with an equal volume of sample buffer 2 3 (125 mM
Tris pH 6.8, 20% glycerol, 10% β-mercapto-ethanol, 4% sodium dodecyl
sulfate), resolved by sodium dodecyl sulfate-polyacrylamide electrophoresis,
followed by wet electrotransfer onto Hybond-C Super membrane (Amersham).
Blocking was performed in 5% nonfat dry milk in PBS-Tween 20 (0.1%) for
at least 1 h at 20°C. The membrane was incubated overnight at 4°C with the
primary antibody, washed, and incubated for 1–2 h at 20°C with the peroxidase
conjugated secondary antibody. Protein bands were visualized using enhanced
chemiluminescence as described by the supplier (Amersham). The antibodies
used were: a mouse monoclonal antibody to VDR (clone IVG8C11; Dame
Figure 1. Suppression of VDR mRNA and induction of RXRa mRNA
during suspension culture of normal keratinocytes. Adherent 70%
confluent keratinocytes (ADH) were brought into semisolid medium for the
indicated time, after which total RNA was prepared for northern blot analysis.
Sequential hybridization was performed with labeled probes for human VDR,
RXRα, SPR 1, transglutaminase I (Tgase I), c-Myc, cyclin D1 (Cycl D1),
p21WAF1, and glyceraldehyde-3-phosphate dehydrogenase.
et al, 1986), rabbit anti-RXRα and rabbit anti-cyclin A (Santa Cruz Biotechno-
logy, Santa Cruz, CA), monoclonal anti-involucrin, and anti-β-actin (Sigma).
Peroxidase conjugated goat anti-rabbit and rabbit anti-mouse (Dako A/S,
Glostrup, Denmark) were used as secondary antibodies. Quantitation of bands
of both northern and western blots was performed using a laser densitometric
scanner (Pharmacia).
RESULTS
Anchorage dependent expression of VDR in normal
keratinocytes When deprived from cell-matrix contact by suspen-
sion culture, keratinocytes are forced into growth arrest, followed by
differentiation and programmed cell death (Rheinwald and Beckett,
1980; Adams and Watt, 1989; Frisch and Ruoslahti, 1997). Accordingly,
we observed a strong suppression of the expression of proto-oncogenes
that reflect a proliferative state: c-myc and cyclin D1 mRNA levels
were reduced by 85% and 90%, respectively, in suspended epidermal
cells (Fig 1). The cyclin-dependent kinase inhibitor p21WAF1, a negative
cell cycle regulator, was induced 5-fold together with a spectacular
more than 100-fold increase of the transcripts for the differentiation
markers SPR 1 (cornified envelope precursor) and its cross-linking
enzyme transglutaminase I. These signs of growth arrest and differenti-
ation were accompanied by dramatic changes in the expression of the
investigated nuclear receptors: VDR mRNA exhibited a more than
70% decrease in suspension culture (Fig 1), this effect started almost
immediately at 2 h to result in a sustained reduction of VDR mRNA
from 4 h on. The mRNA for RXRα, the heterodimeric partner for
VDR, was induced 4 h after detachment of the cells to reach a maximal
10-fold induction after 18 h (Fig 1). With longer time in suspension,
RXRα mRNA declined again (see also Fig 10, lanes 1–3).
After treatment with the RNA synthesis inhibitor actinomycin D,
we observed no difference in the decay of VDR mRNA between
attached and suspended cells (estimated half life 3 h) (Fig 2). In
addition, the time course of VDR mRNA downregulation was the
same in suspended cells with or without actinomycin D (compare
Figs 1, 2). These data imply that the decrease of VDR mRNA in
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Figure 2. Stability of VDR mRNA is unchanged in adherent versus
suspended keratinocytes. Attached or suspended keratinocytes were cultured
in the presence of 10 µg actinomycin D per ml to investigate the decay of
VDR or RXRα mRNA by northern blot analysis.
Figure 3. Anchorage-dependent expression of VDR protein in normal
human keratinocytes. Attached cells (ADH) were forced to suspension culture
for the indicated time. Total protein samples (100 µg) were subjected to
immunoblot analysis with antibodies specific for VDR, RXRα, cyclin A (Cycl
A), and involucrin (Invol).
suspension was not due to decreased mRNA stability but to inhibition
of transcription of the VDR gene. On the other hand, RXRα mRNA
was clearly stabilized in nonattached cells (Fig 2), an effect that may
contribute to the elevated RXRα mRNA levels in suspension (Fig 1).
Immunoblot analysis revealed that VDR and RXRα protein levels
followed the changes observed at the transcriptional level. VDR protein
started to decrease after 8 h and was suppressed by 80%–90% after 1
or 2 d in suspension (Fig 3). The expression pattern of VDR protein
was paralleled by that of cyclin A, a cyclin whose expression is restricted
to the S and G2 phase of the cell cycle (Sherr, 1996). RXRα protein
levels transiently increased after 1 day in suspension (Fig 3).
Decreased 1,25(OH)2D3 responsiveness in suspended
keratinocytes We used 1,25(OH)2D elicited induction of the
mRNA for the enzyme 24-hydroxylase as a biomarker for 1,25(OH)2D3
responsiveness. The promoter of the 24-hydroxylase gene contains at
least two collaborative vitamin D response elements (Omdahl and May,
1997), making it one of the most vitamin D responsive genes in target
cells for 1,25(OH)2D3, including keratinocytes (Chen et al, 1994). Not
unexpectedly, the fall of VDR levels in suspended keratinocytes was
accompanied by a marked decrease of 24-hydroxylase induction in
response to 1,25(OH)2D3. At a concentration of 10
–6 or 10–7 M, a
15 h incubation with 1,25(OH)2D3 induced 24-hydroxylase mRNA
more than 100-fold in adherent keratinocytes, whereas vehicle had no
effect (data not shown). Keratinocytes that were detached for 11 h lost
sensitivity to 1 or 0.1 µM 1,25(OH)2D3 by 85% (Fig 4). With longer
time in suspension, vitamin D responsiveness in the keratinocytes
declined even more (data not shown).
Figure 4. Decreased 1,25(OH)2D3 responsiveness of keratinocytes in
suspension culture. Keratinocytes were plated on plastic or put in suspension
for 11 h. The cells were subsequently stimulated with 1 or 0.1 µM 1,25(OH)2D3
and harvested for RNA isolation 15 h later. Northern blot analysis was
performed to reveal 25-hydroxyvitamin D3-24-hydroxylase (24OHase) mRNA.
Restoration of VDR levels by reattachment of suspended ker-
atinocytes to substrate The dramatic reduction of VDR levels
during suspension culture could not be prevented by either its ligand
1,25(OH)2D3 or by agents that have been shown to inhibit suspension
induced terminal differentiation or nucleosomal fragmentation (data
not shown): fibronectin (Adams and Watt, 1989; Drozdoff and Pledger,
1993), epidermal growth factor (Drozdoff and Pledger, 1993), trans-
forming growth factor β1 (Sachsenmeier et al, 1996), keratinocyte
growth factor (Hines and Allen-Hoffmann, 1996), or retinoic acid
(Yaar et al, 1981). These observations indicate that cell adhesion is an
absolute prerequisite for keratinocytes to express VDR to a normal
extent. Indeed, re-expression of VDR mRNA in suspended ker-
atinocytes could only be achieved by reattachment to substrate.
Suspended cells that were reseeded on tissue culture treated plastic for
6 h, restored mRNA levels for VDR and c-myc and brought mRNA
for p21WAF1 back down to normal levels (Fig 5). A rise in cyclin D1
mRNA occurred somewhat more slowly (Fig 5). Steady state mRNA
levels of the differentiation markers SPR 1 and transglutaminase I
continued to increase for some time after reattachment (Fig 5),
indicating the initiation of a differentiation program that was not
immediately reversed after reacquiring anchorage. RXRα also remained
elevated after replating of the cells (Fig 5), suggesting a differentiation-
related expression of this nuclear receptor.
When suspended keratinocytes were reseeded on fibronectin, medi-
ating α5β1-integrin-dependent attachment (Watt and Hertle, 1994),
VDR, cyclin D1, c-myc, and p21WAF1 mRNA reached the levels of
attached cells already after 3 h (Fig 6), which appears more quickly
than on plastic. Under these conditions, the keratinocytes also adopted
a spread cell shape more readily (data not shown).
The arginine-glycine-aspartate (RGD) sequence in extracellular
matrix molecules like fibronectin is the crucial recognition site for the
interaction with integrins. Therefore, synthetic RGD peptides can
compete with fibronectin for integrin binding, thereby inhibiting
cell adhesion (Koivunen et al, 1994). Suspended keratinocytes were
prevented from reattachment to fibronectin in the presence of 0.6 mg
per ml of the RGD peptide Gly-Arg-Gly-Asp-Thr-Pro (data not
shown). Under these conditions, VDR mRNA levels were not allowed
to increase (Fig 7, lane 4), like in cells attached to fibronectin (Fig 7,
lane 3). The use of a blocking anti-β1 integrin antibody (1/200) as a
different approach to inhibit fibronectin–integrin interaction, produced
similar results (Fig 7, lane 5). From these data, involvement of integrins
554 SEGAERT ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 5. Replating of suspended keratinocytes on plastic leads to re-
expression of VDR mRNA. Adherent keratinocytes (ADH) were suspended
for 5 h, harvested, and replated on plastic in keratinocyte serum free medium
for the indicated time. Northern blot analysis was performed with probes for
the indicated mRNA.
Figure 6. Replating of suspended keratinocytes on fibronectin results
in a rapid restoration of VDR mRNA. Keratinocytes, maintained in
suspension for 7 h, were seeded on fibronectin-coated dishes in keratinocyte
serum free medium for the indicated time. Total RNA samples were subjected
to northern blot analysis to visualize the mRNA for VDR, RXRα, cyclin D1,
and c-myc.
in the anchorage-dependent expression of VDR might be proposed.
The observation that VDR re-expression also occurs on plastic, does
not rule out this possibility but may be explained by deposition of
extracellular matrix components by the keratinocytes, followed by
delayed integrin signaling (Frisch and Ruoslahti, 1997).
Disruption of actin cytoskeleton inhibits VDR expression in
normal keratinocytes In view of the close relation between cell
shape and cell anchorage, illustrated by the rounding of detached cells,
the role of cytoskeletal organization (as a major determinant of cell
shape) was further assessed in the expression of VDR. Cytochalasin D
is a fungal agent that disrupts the actin cytoskeleton by blocking actin
polymerization without interfering with cell adhesion. It was shown
to provoke cell cycle arrest by blocking the expression of adhesion-
dependent cell cycle regulators like cyclin D1 (Bo¨hmer et al, 1996).
Figure 7. RGD peptides and a blocking anti-b1-integrin antibody
inhibit restoration of VDR mRNA on fibronectin. Keratinocytes were
put in suspension culture for 5 h and replated on fibronectin for 5 h in the
presence or absence of Gly-Arg-Gly-Asp-Thr-Pro 0.6 mg per ml (RGD) or a
blocking anti-β1-integrin antibody (1/200). Total RNA was used for northern
analysis to detect VDR mRNA.
Figure 8. Cytoskeletal integrity is required for expression of VDR
mRNA. Attached epidermal keratinocytes were treated with cytochalasin D
1 µM or dimethylsulfoxide 0.1% (veh) for the indicated period of time, followed
by detection of VDR and RXRα mRNA levels.
Figure 9. Disruption of actin cytoskeleton inhibits VDR protein
expression. Keratinocytes were treated with cytochalasin D or
dimethylsulfoxide vehicle after which the indicated proteins were visualized by
western blotting.
Treatment of attached keratinocytes with cytochalasin D led to a rapid
loss of the spread cell shape (data not shown), together with a sustained
70% suppression of VDR mRNA after 4 h (Fig 8) and a 50% decrease
of VDR protein after 10 h (Fig 9). Concomitantly, the cells were
growth arrested as evidenced by loss of cyclin A expression (Fig 9).
RXRα expression was not affected (Figs 8, 9) and mRNA levels for
the differentiation markers transglutaminase and SPR1 also remained
unchanged (data not shown). Taken together, these findings indicate
that the maintenance of VDR expression in keratinocytes depends on
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Figure 10. Squamous cell carcinoma cells display a markedly decreased
anchorage dependence for the expression of VDR. Normal human
epidermal keratinocytes (NHEK) or squamous cell carcinoma cells (SCC12B2
or A431) were maintained in normal adherent cultures (ADH) or in suspension
(SUSP) for 24 or 48 h. Total RNA was used for northern blot analysis to
detect the indicated mRNA.
the integrity of the actin cytoskeleton. The induction of RXRα in
suspension but not by disruption of the cytoskeleton probably refers
to a differentiation-related expression, regardless of cell shape.
Anchorage-independent expression of VDR in malignant
keratinocytes Cancer cells exhibit a markedly reduced dependence
on anchorage for their growth and survival. In view of the anchorage
dependence of VDR expression in normal keratinocytes, we therefore
investigated whether malignant keratinocytes exhibited the same
requirements for maintaining VDR levels. In relation to normal
keratinocytes, SCC12B2 and A431 cells are characterized by an
increased growth rate (A431 . SCC12B2) (data not shown), an
increasingly pronounced anchorage-independent growth (A431 .
SCC12B2) (Rheinwald and Beckett, 1980; Lee et al, 1987) and
resistance to suspension-induced terminal differentiation (Rheinwald
and Beckett, 1980), as shown by the defective induction of SPR 1
and transglutaminase I mRNA as compared with normal keratinocytes
(Fig 10). As reported previously (Kurzrock et al, 1995), the accelerated
growth rate in the squamous cell carcinoma cells was accompanied by
overexpression of cyclin D1 (especially in A431). The failure of the
SCC cells to undergo growth arrest after detachment, was reflected by
the anchorage-independent expression of c-myc and cyclin D1 (Fig 10)
(A431 . SCC12B2). Adherent SCC12B2 and A431 cells contain
VDR mRNA and protein levels comparable with normal keratinocytes
(Ratnam et al, 1996; Fig 10). In contrast to normal keratinocytes,
however, SCC12B2 and A431 displayed an increasing anchorage-
independent expression of VDR (Fig 10) that correlated strikingly
with the decreased adhesion requirement for growth, cyclin D1
and c-myc expression and with increased resistance to induction of
differentiation markers (transglutaminase I and SPR 1) and RXRα
mRNA (Fig 10). These results indicate that the signaling events that
confer anchorage-independent growth in malignant cells, may also
enhance transcription of VDR.
DISCUSSION
Since the discovery of vitamin D receptors in the skin almost 20 y ago
(Stumpf et al, 1979), numerous reports have been published on the
pharmacologic effects of its ligand 1,25(OH)2D3 on normal and
pathologic keratinocytes (Bikle and Pillai, 1993). Nevertheless, the
physiologic role of VDR in the epidermis remains highly enigmatic.
Knowing that steroid receptor levels in target cells fluctuate according
to their functional needs (Krishnan and Feldman, 1997), we investigated
VDR expression in cultured normal keratinocytes and demonstrated
anchorage and cytoskeletal integrity as essential and collaborative
requirements for the expression of VDR and for an optimal
1,25(OH)2D3 responsiveness. In addition, this adhesion-dependent
regulation of VDR levels appears to be perturbed in malignant
keratinocytes in that their anchorage-independent growth conferred
anchorage-independent expression of VDR. In this sense, regulation
of VDR expression is strikingly similar to that of genes involved in
cell cycle regulation [cyclin D1 (Bo¨hmer et al, 1996; Zhu et al, 1996)
and cyclin A (Schulze et al, 1996)] or cell survival [bcl-2 (Zhang et al,
1995) and bcl-xL (Rodeck et al, 1997)].
Anchorage (and shape) dependence of growth of normal cells has
been known for a long time, but could only recently be explained at
the molecular level by the need of cell adhesion for expression of
cyclin D1, activity of cyclin E-cdk2 (by means of decreased levels
of the cyclin-dependent kinase inhibitors p21WAF1 and p27KIP1),
phosphorylation of retinoblastoma protein, and cyclin A expression
(Fang et al, 1996; Schulze et al, 1996; Zhu et al, 1996). Moreover,
retinoblastoma protein phosphorylation correlates well with the cell
cycle restriction point, where cell cycle progression becomes independ-
ent of anchorage or growth factors (Weinberg, 1995). Therefore it is
not surprising that retinoblastoma protein or its upstream regulators
(cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhib-
itors) turn out to be the ultimate targets of cell cycle regulating signals
initiated by adhesion or growth factors (Fang et al, 1996; Zhu et al,
1996). Likewise, we observed that cell adhesion was required for
expression of cyclin D1 and cyclin A, whereas p21WAF1 was induced
by detachment. Cyclin D1 occupies a central position in the portion
of the cell cycle (G1) that depends on adhesion, mitogens, and a spread
cell shape. Integrating signals from both the extracellular matrix and a
diversity of mitogens, cyclin D1 can be considered as a sensor for
environmental stimuli (Sherr, 1996; Assoian, 1997). We report that
cell anchorage and cell shape (in addition to growth factors; Segaert
et al, unpublished results) jointly regulate VDR and cyclin D1 expres-
sion. From these results, it is tempting to speculate that the abundance
of VDR (and maybe of other nuclear receptors) could also be
jointly regulated by signals that depend on adhesion, cell shape, and
growth factors.
Cell anchorage is mainly mediated by integrins, functioning as
receptors for extracellular matrix proteins, thereby initiating signaling
cascades in the cell, leading to focal adhesion assembly, organization
of the cytoskeleton, cell spreading, cell motility, altered gene expression,
proliferation, and cell survival (Frisch and Ruoslahti, 1997; Giancotti,
1997; Meredith and Schwartz, 1997). Our results suggest that integrins
are involved in the transcriptional regulation of the VDR gene:
disruption of cell–matrix interactions suppresses VDR expression;
replating on fibronectin tends to restore VDR levels more rapidly than
on plastic and RGD peptides or a blocking anti-β1-integrin antibody
prevent not only fibronectin–integrin interaction but also induction of
VDR mRNA. Integrins integrate the extracellular matrix with the
intracellular cytoskeleton at focal adhesion complexes. Therefore it is
not surprising that compromizing the cytoskeletal integrity with
cytochalasin D also downregulated VDR levels. Indeed, by a phenom-
enon called tensegrity, the structural organization of the cytoskeleton
determines cell shape that in turn governs cell fate in an absolute way
(Chen et al, 1997; Ingber, 1997). Shape dependence may be closely
related to anchorage dependence because cytoskeletal organization is
adhesion dependent and because the adequate transmission of adhesion-
dependent signals requires an intact cytoskeleton (Zhu and Assoian,
1995; Ingber, 1997). An organized cytoskeleton may serve as a scaffold,
which binds multiple signaling molecules, integrating growth factor
and integrin signaling cascades and enabling them to reach the nucleus
(Ingber, 1997). These different signaling pathways used by integrins
[focal adhesion kinase; PI-3-kinase; ras-mitogen activated protein kinase
(MAPK)] will thus often impinge on growth factor initiated signals
(Schwartz, 1997). This convergence of integrin and growth factor
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pathways is most strikingly observed in the coordinate activation of
the MAPK pathway (Lin et al, 1997). MAPK activation probably needs
to reach a certain threshold level by the joint action of growth factors
and integrins and through an intact cytoskeleton (Zhu and Assoian,
1995) before leading to the induction of proteins involved in cell cycle
progression (cyclin D1; Bo¨hmer et al, 1996) or cell survival (Bcl-2,
Bcl-xL; Zhang et al, 1995; Rodeck et al, 1997) by mechanisms that we
are only beginning to understand (Giancotti, 1997). The lack of VDR
induction by growth factors in suspended keratinocytes in this study
seems to support the view that a common pathway is involved that
needs input from both adhesion and growth factor-dependent signals
via an intact cytoskeleton. Likewise, the anchorage-independent expres-
sion of cyclin D1 and VDR in the investigated cancer cells may arise
from constitutive activation of this pathway (Schwartz, 1997). We have
shown that the regulation of VDR levels occurred most notably at the
transcriptional level. Therefore, the recent characterization of the
promoter region of the human and mouse VDR gene (Jehan and
DeLuca, 1997; Miyamoto et al, 1997) holds promise to further
elucidate the signals and transcription factors involved in this intriguing
regulation. In this context, it is of great interest that the VDR gene
promoter contains binding sites for transcription factors (AP1, AP2,
Sp1) that have a prominent role in the regulation of epidermal gene
expression (Eckert et al, 1997b). Finally, changes in intracellular
calcium have also been implicated in suspension-induced keratinocyte
differentiation (Li et al, 1996); however, this possibility seems unlikely
because we observed no differences in VDR mRNA levels when
extracellular calcium concentrations were elevated to 1.8 mM in
adherent keratinocyte cultures (Segaert et al, unpublished results).
As a whole, this study raises evidence that nuclear receptor function
might be connected with the complex crosstalk between integrin and
growth factor signals in which integrins can modulate the ability of
cells to respond to growth factors and vice versa (Schwartz, 1997); in
addition cell adhesion (this study) and growth factor-dependent signals
(Krishnan and Feldman, 1991) may also coordinately regulate the
response of cells to steroid hormones. Because nuclear receptor ligands
have free access to the nucleus, regulation of nuclear receptor activity
is crucial to impose a functional control by the environment. This
purpose may be accomplished by receptor phosphorylation (Hsieh et al,
1993; Kato et al, 1995; Krstic et al, 1997) in response to signaling
pathways, initiated by mitogens or extracellular matrix proteins. Regula-
tion of nuclear receptor abundance may represent an additional
mechanism whereby extracellular matrix, cell shape, and growth factors
control nuclear receptor function.
We describe that VDR is most notably expressed in proliferating
cells, which are attached to substrate and adopt a spread shape to
express growth-related genes like cyclin D1 and c-myc. That the level
of proliferation determines the VDR content was also underscored
previously by an association between the expression of c-myc and
VDR in osteosarcoma cells (Manolagas et al, 1987) (as we now confirm
in keratinocytes) and by an inverse correlation between 1,25(OH)2D3
binding and keratinocyte differentiation (Pillai et al, 1988) (as in our
study). Previously, it was shown that the magnitude of the anti-
proliferative effect exerted by 1,25(OH)2D3 in keratinocytes correlated
with the cellular growth rate (Gniadecki, 1996a): in keratinocytes that
were committed to differentiate (among others by suspension culture),
the 1,25(OH)2D3 anti-proliferative effect was attenuated and concentra-
tions in the nanomolar range even stimulated DNA synthesis. These
mitogenic properties of calcitriol were later attributed to rapid induction
of the ras-raf-mitogen-activated protein kinase pathway (Gniadecki,
1996b), which occurs most likely independently of transcription. We
believe that our results add to the understanding of these effects of
1,25(OH)2D3 by the demonstration that VDR levels and vitamin D
responsiveness in keratinocytes fluctuate according to the proliferation
and differentiation state as influenced by cell–matrix interactions.
Indeed, keratinocytes from patients with vitamin D-dependent rickets
type II, characterized by the lack of transcriptional activation of VDR
by 1,25(OH)2D3 (Malloy et al, 1997), are resistant to growth inhibition
by calcitriol (Arase et al, 1991). Thus the growth inhibitory effects of
calcitriol probably relate to VDR transcriptional activity (and thus to
VDR levels), whereas the mitogenic effects may emerge from rapid
activation of signaling cascades independently of VDR-initiated tran-
scription. The cellular response to 1,25(OH)2D3 will finally be the
result of the balance between transcriptional effects (which are more
pronounced with increasing VDR levels and 1,25(OH)2D3 concentra-
tions) and rapid effects. This hypothesis also offers an explanation for
the therapeutic efficacy of vitamin D analogs in hyperproliferative
versus retention-type cornification disorders (Kragballe et al 1995) and
reconciles the paradoxical data regarding effects of vitamin D analogs
on normal (pro-proliferative) (Gniadecki and Serup, 1995) versus
psoriatic (antiproliferative) epidermis (van de Kerkhof, 1995; Fogh and
Kragballe, 1997). Indeed, VDR is overexpressed in psoriatic epidermis
by increased suprabasal expression (Milde et al, 1991) whereas its
expression in normal epidermis is largely restricted to basal cells (Stumpf
et al, 1979; Merke et al, 1985; Milde et al, 1991), like it is the case for
integrins (Watt and Hertle, 1994). Moreover, transgenic mice engine-
ered to overexpress the keratinocyte stem cell marker β1-integrin in
the suprabasal epidermal layers exhibit a psoriasis-like phenotype
(Carroll et al, 1995), with the emergence of proliferating cells in the
suprabasal compartment of the epidermis. Although VDR expression
was not investigated in these mice, these findings may contribute to
the evidence of a link between keratinocyte integrins on the one
hand, and keratinocyte proliferation (Watt and Hertle, 1994), survival
(Rodeck et al, 1997), and possibly VDR expression (this study) on the
other hand. Besides, the anchorage dependence of VDR in our system
is also in line with the contention that basal keratinocytes, expressing
VDR to the largest extent (Stumpf et al, 1979; Merke et al, 1985;
Milde et al, 1991), represent the preferential target cells for 1,25(OH)2D3
in the epidermis. Because of their constitutive anchorage-independent
expression of VDR, squamous cell carcinoma cells could be proposed
as attractive therapeutic targets for vitamin D compounds, but con-
versely, lack of transcriptional activation of VDR by its ligand (Xie
and Bikle, 1998) seems to confer vitamin D unresponsiveness in these
cells (Ratnam et al, 1996).
VDR-dependent transcription is usually mediated by VDR-RXR
heterodimers (Haussler et al, 1997; Li et al, 1997b). RXRα, accounting
for 90% of RXR in human epidermis (Fisher and Voorhees, 1996),
was strongly induced in keratinocytes in suspension culture. This
observation is in accordance with the higher RXRα mRNA level in
epidermis in vivo as compared with cultured keratinocytes (Mangelsdorf
et al, 1992), which may reflect the preponderance of suprabasal
keratinocytes in epidermis in vivo as compared with a monolayer in vitro.
The importance of suprabasal RXRα in mediating the function of
partner nuclear receptors in the epidermis, was recently demonstrated
(Feng et al, 1997). The concomitant changes in VDR and RXRα
expression we report in suspended keratinocytes (which stand model
for differentiating suprabasal cells) imply a drastic increase in the
RXRα/VDR ratio. Because an excess of RXR allows positive co-
operativity between 1,25(OH)2D3 and RXR ligands in the transcription
of vitamin D-dependent genes (Schra¨der et al, 1995), the relative levels
of RXR and VDR may explain the different outcome of combinations
of retinoids and vitamin D compounds in vivo (synergistic induction
of 24-hydroxylase; Kang et al, 1997, Li et al, 1997b) versus in vitro
[mainly antagonism (Segaert et al, 1997; Gibson et al, 1998), also with
respect to 24-hydroxylase induction (Segaert et al, unpublished results)].
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